Skip to main content
. 2020 Jan 7;21(2):381. doi: 10.3390/ijms21020381
CAR Chimeric antigen receptor
OC Ovarian cancer
mAb Monoclonal antibody
ANXA2 Annexin A2
EMT Epithelial-mesenchymal transition
E:T Effector-to-target
PBMC Peripheral blood mononuclear cell
NIKO NOD-scid IL-2Rγ-Knock-Out